Results 1 to 10 of about 16,856 (193)

The Relationship of Fractional Exhaled Nitric Oxide in Patients with AECOPD [PDF]

International Journal of COPD, 2023
Xiaoguang Xu,1,2 Lefei Zhou,3 Zhaohui Tong1 1Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Department of ...
Xu X, Zhou L, Tong Z
doaj   +5 more sources

Estimating nasal nitric oxide from measured fractional exhaled nitric oxide and nasal fractional exhaled nitric oxide. [PDF]

J Thorac Dis
Background Nasal nitric oxide (nNO) is an effective screening indicator for primary ciliary dyskinesia (PCD) and a potential biomarker for nasal diseases; however, Measurement of nNO using standard methods is not available everywhere. Therefore, we aimed
Abo M, Tsumaya Y, Ohki T, Takeda Y, Kobayashi T, Ueno T, Matsuda Y, Nakade Y, Yamamura K, Watanabe S, Ohkura N, Hara J, Yano S, Gon Y.   +13 more
europepmc   +3 more sources

Application of fractional exhaled nitric oxide and nasal nitric oxide in the evaluation of asthma control [PDF]

Frontiers in Pediatrics, 2023
BackgroundAsthma is the most common chronic respiratory disease in childhood, and effective control of airway inflammation is crucial in its management.
Yucong Ma, Wenying Lin, Haoqi Zheng, Yang Wang, Jingjing Cui, Li Liu   +5 more
doaj   +4 more sources

Fractional Exhaled Nitric Oxide in Teenagers and Adults with Atopic Dermatitis. [PDF]

Adv Respir Med, 2022
Fractional exhaled nitric oxide (FeNO) is a non-invasive biomarker of eosinophilic airway inflammation and therapeutic response to corticosteroid treatment of respiratory diseases. Atopic dermatitis (AD), one of the most common allergic conditions of the skin, is a factor influencing the increase of FeNO.
Galiniak S, Rachel M.
europepmc   +4 more sources

Measurements of fractional exhaled nitric oxide in pediatric asthma [PDF]

Korean Journal of Pediatrics, 2013
Exhaled nitric oxide (NO) has been extensively investigated as a noninvasive marker of airway inflammation in asthma. The increased NO expression induced by inflammatory mediators in airways can be monitored easily in exhaled air from asthmatic children.
Youn-Soo Hahn
doaj   +3 more sources

Fractional Exhaled Nitric Oxide in Eosinophilic COPD. [PDF]

Chronic Obstr Pulm Dis
Eosinophilic chronic obstructive pulmonary disease (COPD) is a distinct subtype with clinical and biological differences from noneosinophilic COPD and asthma. Fractional exhaled nitric oxide (FeNO) is an established marker of type 2 airway inflammation in asthma, but its utility in eosinophilic COPD is less well understood.
Morejon-Jaramillo PE, Ni W, Nassikas N, Synn A, Elfeshawy M, Denoncourt C, Schortmann S, Coull B, Rebuli M, Phipatanakul W, Rice MB.   +10 more
europepmc   +4 more sources

Is fractional exhaled nitric oxide a treatable trait in chronic cough: a narrative review. [PDF]

J Thorac Dis, 2023
Background and Objective Current management of chronic cough is largely based on sequential therapeutic trials. The concept of treatable traits was first introduced for individualized treatment of chronic airway diseases; however, it has emerged as a ...
Lee JH, Lee JH, Park SY, Koskela HO, Song WJ.   +4 more
europepmc   +2 more sources

Treatment guided by fractional exhaled nitric oxide in addition to standard care in 6- to 15-year-olds with asthma: the RAACENO RCT

Efficacy and Mechanism Evaluation, 2022
Background: The role of fractional exhaled nitric oxide in guiding asthma treatment in children is uncertain. Objective: To compare treatment guided by both fractional exhaled nitric oxide and symptoms (intervention) with treatment guided by symptoms ...
Steve Turner, Seonaidh Cotton, Jessica Wood, Victoria Bell, Edwin-Amalraj Raja, Neil W Scott, Heather Morgan, Louisa Lawrie, David Emele, Charlotte Kennedy, Graham Scotland, Shona Fielding, Graeme MacLennan, John Norrie, Mark Forrest, Erol Gaillard, Johan de Jongeste, Marielle Pijnenburg, Mike Thomas, David Price   +19 more
doaj   +2 more sources

An Overview of Fractional Exhaled Nitric Oxide and Children with Asthma [PDF]

Expert Review of Clinical Immunology, 2016
Asthma is the most common pediatric chronic disease and is characterized by lung inflammation. Fractional exhaled nitric oxide (FeNO) is thought to reflect the presence of eosinophilic airway inflammation, and is an easy, non-invasive test that has held promise in providing additional objective data.
Wanda Phipatanakul
exaly   +3 more sources

The value of fractional exhaled nitric oxide in occupational diseases - a systematic review. [PDF]

J Occup Med Toxicol, 2022
Fractional exhaled nitric oxide (FeNO) is a non-invasive biomarker of respiratory tract inflammation, originally designated to identify eosinophilic airway inflammation and to predict steroid response.
Oțelea MR, Fell AKM, Handra CM, Holm M, Filon FL, Mijakovski D, Minov J, Mutu A, Stephanou E, Stokholm ZA, Stoleski S, Schlünssen V.   +11 more
europepmc   +2 more sources